ACL Australian Clinical Labs Ltd
- 3.410
- +0.030+0.89%
Australian Clinical Labs Ltd News
ASX All Ords Share Higher Despite Major Shareholder Cashing Out 30% Stake
Wall Street Analysts Are Bullish on Top Healthcare Picks
Australian Clinical Labs Names Matthew Cordingley as CFO
Australian Clinical Labs Ltd (ACL) Gets a Buy From Ord Minnett
Australian Clinical Labs Price Target Raised 4.7% to A$3.35/Share by Ord Minnett
Australian Clinical Labs Ltd To Go Ex-Dividend On September 4th, 2024 With 0.09 AUD Dividend Per Share
Australian Clinical Labs Posts Lower Profit in Fiscal 2024
Australian Clinical Labs Ltd: FY24 financial results investor presentation
Australian Clinical Labs Ltd: Appendix 4E and FY24 financial statements
Do Its Financials Have Any Role To Play In Driving Australian Clinical Labs Limited's (ASX:ACL) Stock Up Recently?
Australian Clinical Labs to Unveil FY24 Results
Citigroup Increases Stake in Australian Clinical Labs
Allan Gray Australia Acquires 5% Stake in Clinical Labs
Substantial Shareholder Ups Stake in Australian Clinical Labs
New Substantial Shareholder in Australian Clinical Labs
Australian Clinical Labs Limited's (ASX:ACL) Intrinsic Value Is Potentially 85% Above Its Share Price
Australian Clinical Labs Started With A$3.20/Share Target Price by Ord Minnett>ACL.AU
Australian Clinical Labs Started at Buy by Ord Minnett >ACL.AU
Ord Minnett Starts Australian Clinical Labs at Buy, Price Target Is AU$3.50
3 ASX 300 Shares Hitting New 52-week Lows: Are They Cheap Buys?
Analysis
Price Target
No Data
No Data